There are investigations showing that CXCL3 is associated with vascular invasion and tumor capsule formation in HCC and is targeted by IRF2 to suppress MDSC migration and infiltration in colorectal cancer (54, 56). Here, CXCL3 is linked to hepatocellular carcinoma.